Medfinder
Back to blog

Updated: January 18, 2026

Testim Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Summarize with AI


Overview

Testim isn't in a formal shortage, but access problems are real in 2026. Get the latest on testosterone gel availability and steps you can take to fill your prescription.

Is Testim in stock near you?

Medfinder checks real pharmacy inventory — start a search and we'll find Testim near you.

If you've been struggling to fill your Testim prescription in 2026, you're not imagining things. While Testim isn't officially listed on the FDA's drug shortage database, real-world access challenges — from cost and insurance barriers to limited pharmacy stocking — have made it genuinely difficult for many patients to get their medication.

This article gives you an honest, up-to-date picture of what's happening with Testim availability and what you can do about it.

Is Testim in a Formal Drug Shortage in 2026?

No. As of early 2026, Testim (brand-name testosterone 1% gel) is not on the FDA's official drug shortage list. The FDA's shortage database primarily reflects formal reports from manufacturers about inability to meet demand — and no such formal report has been filed for Testim or testosterone gel formulations.

However, "not officially in shortage" doesn't mean "readily available." Access problems are real and stem from several intersecting factors.

Don't wait on hold.
Check live stock now.

The Testosterone Supply Picture in 2026

To understand Testim's access problems, it helps to look at the broader testosterone market:

Injectable testosterone (Testosterone Cypionate / Depo-Testosterone): Has been in intermittent shortage since early 2023. As of April 2026, Testosterone Cypionate remains on the ASHP shortage list. The 100 mg/mL 10 mL vials have been on extended back order.

Generic testosterone gel (1% and 1.62%): Generally available, but demand has increased as patients switch away from injectable testosterone.

Brand testosterone gels (AndroGel, Testim, Fortesta): Available but expensive without insurance, and Testim in particular is less commonly stocked than AndroGel.

Why Testim Is Hard to Access Even Without a Formal Shortage

Several factors combine to create access problems for Testim patients:

1. Most Pharmacies Don't Routinely Stock Testim

Testim occupies a smaller share of the testosterone gel market compared to AndroGel. Many large pharmacy chains (CVS, Walgreens, Rite Aid) prioritize stocking generic testosterone gel and AndroGel rather than Testim. This means patients with a Testim prescription often need to seek out pharmacies that will special-order it.

38,920+ patients found their medications in stock
38K+
5-star rating

2. Rising TRT Demand Puts Pressure on All Formulations

The number of testosterone prescriptions written in the U.S. has grown significantly over the past decade, driven by increased awareness of "Low T," direct-to-consumer advertising, and the rise of telehealth TRT clinics. More patients on TRT means more demand hitting all testosterone products — including Testim.

3. DEA Production Quotas Limit Overall Supply

Because testosterone is a Schedule III controlled substance, the DEA sets annual limits on how much manufacturers can produce. These quotas are based on historical demand and can lag behind real-world prescription volume. When demand grows faster than quotas allow, supply constraints emerge across all testosterone formulations.

Skip the calls, skip the stress.
50K+
Medications
Found
99%
Success
Rate
6+
Hours saved
on average

4. Cost and Insurance Barriers

Brand-name Testim costs $380–$760/month at retail without insurance. Most insurance plans require prior authorization for brand-name testosterone gels, and many Medicare Part D plans don't cover them at all. When patients can't afford their medication, prescriptions go unfilled — which shows up in pharmacy data as reduced demand and leads to even less stocking.

What Patients Should Do Now

Use medfinder to find stock near you. medfinder calls pharmacies in your area to check which ones can fill your Testim prescription, saving you hours on the phone.

Ask about generic testosterone 1% gel. This is the same drug as Testim at a fraction of the cost, and it's widely available. Ask your doctor or pharmacist if a generic substitution is appropriate.

Refill early. Don't wait until you're out. Refill your Testim 5-7 days before you run out to allow time to locate stock if needed.

Try independent pharmacies. Independent and specialty pharmacies often source from different wholesalers and may stock or special-order Testim more readily than chains.

Check savings programs. Endo Pharmaceuticals offers patient assistance programs for eligible patients. Call 1-800-462-3636, or ask your pharmacist about GoodRx and SingleCare coupons for generic testosterone gel.

Talk to your doctor about alternatives. If Testim consistently isn't available, other formulations may work just as well for you. See our guide to alternatives to Testim for a full rundown.

The Bottom Line

Testim is not in a formal FDA shortage in 2026, but access challenges are real — driven by cost, insurance barriers, limited stocking, DEA quota limits, and surging TRT demand. The key is knowing your options and acting proactively. Don't wait until you're out of medication to start looking for your next fill.

Frequently Asked Questions

No. As of early 2026, Testim and other testosterone gel formulations are not on the FDA's official drug shortage list. The formal shortage primarily affects injectable Testosterone Cypionate. However, many Testim patients still encounter access difficulties due to limited pharmacy stocking and cost barriers.

Many pharmacies don't routinely stock Testim because it's less commonly prescribed than AndroGel. Cost without insurance ($380–$760/month) deters many patients, and DEA scheduling limits pharmacy ordering. Call ahead or use medfinder to find pharmacies that have it in stock or can order it.

Yes. Injectable Testosterone Cypionate (Depo-Testosterone) has been in intermittent shortage since early 2023 and remains on the ASHP shortage list as of April 2026. This has pushed more patients toward gel formulations like Testim, increasing demand.

Testim itself isn't in a formal supply shortage, so improvements will come from reduced demand pressure (as injectable shortages ease) and greater awareness of generic alternatives. Using generic testosterone 1% gel is the most reliable way to avoid stocking issues.

Yes. Compounding pharmacies can prepare custom testosterone formulations when commercial products are difficult to obtain. However, compounded testosterone is not FDA-approved, and insurance typically doesn't cover it. Prices vary but often run $40–$90/month. Always use a licensed, PCAB-accredited compounding pharmacy.

How do I find Testim in stock near me?
Medfinder checks real pharmacy inventory and finds the pharmacies that have it.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Testim also looked for:

38,920 have already found their meds with Medfinder.

Start your search today.

38K+
5-star ratingTrusted by 38,920 Happy PatientsRead our reviews on Trustpilot →
      What med are you looking for?
⊙  Find Your Meds

Your information is private and never shared.

99% success rate
Fast turnaround time
Never call another pharmacy

Find Testim in stock